eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
3/2024
vol. 49
 
Share:
Send email
Share:
Review paper

Novel IL2RG gene mutation causing primary combined immunodeficiency disease: A case report and literature review

Fang Cao
1
,
Yingyu Shi
1
,
Fang Deng
1
,
Yu Yan
1

  1. Anhui Provincial Children’s Hospital, China
Cent Eur J Immunol 2024; 49 (3): 300-307
DOI: https://doi.org/10.5114/ceji.2024.142340
Online publish date: 2024/09/20
Article file
- Novel IL2RG gene (1).pdf  [0.66 MB]
Get citation
 
PlumX metrics:
 
1. Dvorak CC, Haddad E, Heimall J, et al. (2023): The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions. J Allergy Clin Immunol 151: 539-546.
2. Roifman CM, Somech R, Kavadas F, et al. (2012): Defining combined immunodeficiency. J Allergy Clin Immunol 130: 177-183.
3. Kohn LA, Kohn DB (2021): Gene therapies for primary immune deficiencies. Front Immunol 12: 648951.
4. Justiz Vaillant AA, Stang CM (2023): Lymphoproliferative disorders. In: StatPearls. StatPearls Publishing.
5. Aytekin G, Vaqar S (2023): X-linked immunodeficiency. In: StatPearls. StatPearls Publishing.
6. Justiz Vaillant AA, Qurie A (2023): Immunodeficiency. In: StatPearls. StatPearls Publishing.
7. Allenspach EJ, Rawlings DJ, Petrovic A, Chen K (2003): X-linked severe combined immunodeficiency. In: Adam MP et al. (Eds.). GeneReviews®. University of Washington, Seattle.
8. Chen KR (2024): Cutaneous vasculitis in autoinflammatory diseases. J Dermatol 51: 150-159.
9. Hou Y, Gratz HP, Ureña-Bailén G, et al. (2021): Somatic reversion of a novel IL2RG mutation resulting in atypical X-linked combined immunodeficiency. Genes 13: 35.
10. Zhang H, Liao Y, Zhu Z, et al. (2024): Assistance of next-generation sequencing for diagnosis of disseminated Bacillus Calmette-Guerin disease with X-SCID in an infant: a case report and literature review. Front Cell Infect Microbiol 14: 1341236.
11. Mahdavi FS, Keramatipour M, Ansari S, et al. (2021): X-linked SCID with a rare mutation. Allergy Asthma Clin Immunol 17: 107.
12. Brault J, Liu T, Liu S, et al. (2023): CRISPR-Cas9-AAV versus lentivector transduction for genome modification of X-linked severe combined immunodeficiency hematopoietic stem cells. Front Immunol 13: 1067417.
13. Bandari AK, Bhat S, Archana MV, et al. (2019): Family-based next-generation sequencing study identifies an IL2RG variant in an infant with primary immunodeficiency. OMICS 23: 285-290.
14. Wadbudhe AM, Meshram RJ, Tidke SC (2023): Severe combined immunodeficiency (SCID) and its new treatment modalities. Cureus 15: e47759.
15. Belaid B, Lamara Mahammed L, Mohand Oussaid A, et al. (2021): Case report: Interleukin-2 receptor common gamma chain defect presented as a hyper-IgE syndrome. Front Immunol 12: 696350.
16. Avery L, Robertson TF, Wu CF, et al. (2022): A murine model of X-linked moesin-associated immunodeficiency (X-MAID) reveals defects in T cell homeostasis and migration. Front Immunol 12: 726406.
17. Noguchi M, Yi H, Rosenblatt HM, et al. (1993): Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73: 147-157.
18. Puck JM, Deschênes SM, Porter JC, et al. (1993): The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1. Hum Mol Gen 2: 1099-1104.
19. Hsu AP, Pittaluga S, Martinez B, et al. (2015): IL2RG reversion event in a common lymphoid progenitor leads to delayed diagnosis and milder phenotype. J Clin Immunol 35: 449-453.
20. Arcas-García A, Garcia-Prat M, Magallón-Lorenz M, et al. (2020): The IL-2RG R328X nonsense mutation allows partial STAT-5 phosphorylation and defines a critical region involved in the leaky-SCID phenotype. Clin Exp Immunol 200: 61-72.
21. Lan T, Luo M, Wei X (2021): Mesenchymal stem/stromal cells in cancer therapy. J Hematol Oncol 14: 195.
22. Hines MR, Knight TE, McNerney KO, et al. (2023): Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome. Transplant Cell Ther 29: 438.e1-438.e16.
23. DeWolf S, Laracy JC, Perales MA, et al. (2022): SARS-CoV-2 in immunocompromised individuals. Immunity 55: 1779-1798.
24. Burroughs L, Woolfrey A (2010): Hematopoietic cell transplantation for treatment of primary immune deficiencies. Cell Ther Transplant 2: 10.3205/ctt-2010-en-000077.01.
Copyright: © 2024 Polish Society of Experimental and Clinical Immunology This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.